Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49452,298,1.77 [1.36-2.31],2.6333121826219343e-05
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51237,395,1.39 [1.10-1.75],0.0056957261504339
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",50709,2761,1.37 [1.25-1.50],3.452740328477275e-12
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Candidiasis,51276,859,1.27 [1.08-1.49],0.0032031282544669
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,49724,7005,1.22 [1.16-1.30],1.9411108465516315e-12
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49927,6407,1.33 [1.26-1.41],1.0822494151541896e-21
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,50767,2426,1.28 [1.16-1.41],4.018134317082483e-07
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51092,173,2.25 [1.61-3.16],2.428247611724901e-06
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47174,1944,1.48 [1.33-1.65],5.85405993763022e-13
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45578,2207,1.65 [1.50-1.83],4.6684059504710843e-23
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45317,516,1.66 [1.35-2.05],1.7283027022919846e-06
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36001,3969,1.29 [1.19-1.39],5.6096769960057156e-11
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45009,781,1.71 [1.44-2.02],4.870683756704133e-10
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51204,2863,1.27 [1.17-1.39],7.493974008268916e-08
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Mycoses,51433,1016,1.25 [1.08-1.45],0.0024863797363403
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,49802,1854,1.52 [1.36-1.69],2.488545964367277e-14
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51298,2144,1.43 [1.29-1.58],2.390707052914307e-12
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48738,397,1.39 [1.10-1.76],0.0060464891392057
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51534,99,1.26 [0.79-2.02],0.3329921140275584
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51029,1875,1.43 [1.28-1.59],6.756672677704083e-11
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51071,152,1.00 [0.69-1.47],0.9859778264884128
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51375,316,1.52 [1.17-1.97],0.001813705437877
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51337,278,1.49 [1.12-1.97],0.0053446218058305
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48780,832,1.57 [1.33-1.84],4.8509449318879134e-08
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48503,555,1.28 [1.05-1.57],0.0146234702610579
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48562,221,1.87 [1.38-2.54],5.873028431510311e-05
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51490,103,1.77 [1.14-2.76],0.0117105559914496
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51401,305,1.12 [0.86-1.47],0.4011729206280311
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral warts,51195,99,1.07 [0.66-1.71],0.7907707546846905
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51227,131,1.06 [0.70-1.60],0.7787369929522486
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm,50943,588,0.96 [0.79-1.17],0.7146214640295897
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51358,115,1.27 [0.82-1.97],0.2801964206542188
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51320,124,1.02 [0.67-1.56],0.9150410076585374
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23691,131,1.05 [0.70-1.60],0.800454461324821
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",50870,2884,0.91 [0.84-1.00],0.0458653061131337
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of meninges,51506,114,1.03 [0.66-1.60],0.906334390612366
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51402,129,0.97 [0.64-1.48],0.9045966269029998
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51483,216,1.04 [0.76-1.44],0.7871316651036231
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of ovary,27709,181,0.89 [0.63-1.27],0.5334111526535978
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51489,725,0.95 [0.80-1.13],0.5619759642770437
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Caecum,51489,597,0.86 [0.70-1.04],0.1139100173184964
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51315,145,0.89 [0.60-1.31],0.548351718814944
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Descending colon,51483,433,0.73 [0.58-0.92],0.0077053035079267
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Rectum,51406,705,0.99 [0.82-1.18],0.8747204933753269
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51301,1232,0.93 [0.82-1.07],0.3230673023209697
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51471,861,0.82 [0.70-0.96],0.0155294290752331
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Carcinoma in situ of breast,22524,138,1.31 [0.88-1.97],0.184043017138291
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22614,165,1.06 [0.73-1.53],0.7755586638933161
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41027,103,1.45 [0.91-2.30],0.1141078083291565
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41061,137,0.93 [0.62-1.39],0.729805106373598
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51435,238,0.68 [0.50-0.93],0.0161498348841289
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Haemangioma, any site",51436,233,0.68 [0.50-0.92],0.0142726987774404
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Leiomyoma of uterus,26793,591,0.70 [0.58-0.86],0.0004115257460256
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Lung cancer and mesothelioma,35727,664,0.76 [0.64-0.92],0.0039664640063415
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Lymphoid leukaemia,41027,103,1.02 [0.64-1.62],0.9390204465799252
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41300,376,1.40 [1.10-1.79],0.0070264629953053
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41333,409,0.90 [0.72-1.14],0.3903709266409793
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22752,190,0.74 [0.52-1.04],0.0815731132437584
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41086,162,1.14 [0.79-1.65],0.4826548631337964
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41135,211,1.29 [0.93-1.77],0.1259572905011372
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41120,196,0.97 [0.69-1.36],0.8698665757818725
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22706,144,1.08 [0.73-1.60],0.7154663875587269
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41109,185,1.07 [0.76-1.51],0.706287794681765
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19755,1393,1.10 [0.97-1.25],0.1472905124111568
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41154,230,0.98 [0.72-1.34],0.896644722283815
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41071,147,0.57 [0.38-0.84],0.0045831053300691
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41134,210,1.43 [1.03-1.98],0.0311072278500656
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanocytic naevi,51142,405,1.14 [0.90-1.44],0.2819491194774771
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanocytic naevi of trunk,51453,174,1.16 [0.81-1.66],0.4205791273234472
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanoma in situ,40993,164,0.76 [0.53-1.11],0.1554089151994277
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41104,180,1.00 [0.70-1.42],0.9927748255030256
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41247,323,0.95 [0.73-1.24],0.6970799586726197
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41375,451,0.73 [0.58-0.91],0.0043661011897609
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41122,198,1.12 [0.80-1.56],0.5195105051960145
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Other benign neoplasms of skin,51175,311,1.13 [0.86-1.48],0.3700996006521625
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43081,2157,1.21 [1.09-1.34],0.0003034106423217
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43198,2274,1.23 [1.11-1.35],5.015327751589916e-05
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50944,682,1.30 [1.09-1.55],0.0042390816245684
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,47752,220,6.01 [4.56-7.92],4.3521834302522505e-37
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50405,143,1.48 [1.01-2.19],0.0469903269505559
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49954,5804,1.26 [1.18-1.34],5.41180645094454e-13
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,48590,99,2.83 [1.81-4.40],4.385471421960232e-06
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,50700,102,1.18 [0.74-1.88],0.4763731912553822
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50570,3038,1.48 [1.36-1.62],1.102728839677549e-19
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50568,3036,1.48 [1.36-1.62],1.212534636140558e-19
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,47705,173,1.93 [1.35-2.76],0.0002941724531324
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,50881,2390,1.13 [1.02-1.24],0.0153302656857837
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,50826,228,2.17 [1.60-2.93],4.510897674392638e-07
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50392,130,1.37 [0.91-2.07],0.1274237783398443
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50381,119,1.26 [0.82-1.94],0.2842357479419416
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51154,556,1.55 [1.28-1.89],1.017108348191631e-05
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51322,113,0.76 [0.48-1.18],0.2207333854427334
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51058,460,1.61 [1.30-2.00],1.2856339663895484e-05
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,48703,212,1.18 [0.85-1.63],0.3210573345992352
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39842,633,1.95 [1.62-2.35],2.527068499232573e-12
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48049,231,0.85 [0.62-1.16],0.3111180197027983
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48076,258,1.12 [0.83-1.50],0.4705140402335375
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39318,109,0.81 [0.51-1.30],0.3910284291587805
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,47853,136,1.61 [1.09-2.39],0.0170809101446682
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,46722,469,1.22 [0.98-1.52],0.0705918814944535
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",50588,1135,1.33 [1.16-1.53],4.655302504938794e-05
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,49984,531,1.09 [0.89-1.33],0.4234649003857497
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,49709,256,0.86 [0.64-1.15],0.3063645731851072
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,50829,3112,1.02 [0.94-1.12],0.570055821160637
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44894,3017,1.00 [0.92-1.09],0.9370579675106302
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39345,136,1.13 [0.74-1.72],0.5625042583705868
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47500,158,1.33 [0.92-1.94],0.1311510232879355
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39771,562,1.50 [1.22-1.84],9.386228957979916e-05
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39332,123,1.16 [0.74-1.80],0.5150531921197166
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46285,7076,0.80 [0.75-0.85],1.7150360227391402e-14
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39592,383,1.15 [0.90-1.48],0.2563382205703648
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40318,1109,1.21 [1.05-1.40],0.0093645995914631
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51370,650,2.24 [1.87-2.67],5.512685930256387e-19
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50997,277,4.13 [3.21-5.31],2.475246069426984e-28
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39463,254,1.23 [0.91-1.67],0.1843770543742079
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39330,121,1.64 [1.06-2.55],0.0266456418399482
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50446,3104,1.16 [1.06-1.26],0.0006911975252435
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39728,519,3.05 [2.49-3.72],7.9601347861687805e-28
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39803,594,2.80 [2.31-3.38],2.3744377205360392e-26
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40473,1264,0.89 [0.77-1.02],0.0859595743387159
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39449,240,1.38 [1.01-1.89],0.0428990190300586
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50980,260,4.28 [3.30-5.54],3.1456528173605597e-28
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40411,1202,1.53 [1.33-1.75],2.011783776963068e-09
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40169,960,1.22 [1.05-1.43],0.0118694947844933
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46388,135,1.59 [1.06-2.39],0.023584645892625
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49183,9974,0.93 [0.89-0.98],0.0038409052055463
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47440,98,1.89 [1.19-3.01],0.0074290282706146
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47455,113,0.92 [0.59-1.45],0.7258734115604103
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51160,3883,0.98 [0.91-1.06],0.6568013966877536
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51162,3878,0.99 [0.91-1.07],0.7325609603299259
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47447,105,1.36 [0.86-2.15],0.1842986702070494
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,50850,2412,1.01 [0.92-1.12],0.7797438771223157
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42371,3162,1.49 [1.37-1.62],1.3598655623419664e-20
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51508,453,2.09 [1.70-2.58],3.990837024200931e-12
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,49619,166,1.20 [0.84-1.73],0.3139914457563501
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,48646,208,1.37 [0.99-1.89],0.0542184465893071
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,48720,282,0.80 [0.60-1.06],0.1213417000082794
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39545,336,1.18 [0.90-1.53],0.2302921326368762
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46880,309,1.18 [0.90-1.54],0.2292421054039711
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4246,172,2.58 [1.89-3.51],1.899901106982033e-09
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4525,508,1.42 [1.17-1.72],0.0003096370004471
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,46698,127,1.54 [1.01-2.34],0.0445709812418926
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4184,113,7.34 [5.34-10.09],1.032091568491466e-34
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50252,3681,0.53 [0.49-0.58],1.214008542869433e-53
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50158,705,1.19 [1.00-1.42],0.0469267465547746
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,46984,731,1.22 [1.03-1.46],0.0235701451895219
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40750,1541,1.51 [1.34-1.71],3.358500801313876e-11
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51307,482,2.30 [1.88-2.82],8.341219375885941e-16
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49283,326,0.76 [0.58-0.98],0.0370731957115652
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Angina pectoris,47054,2383,0.74 [0.67-0.82],1.862262954105345e-09
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49438,481,0.85 [0.68-1.05],0.1374434989956063
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49077,120,2.30 [1.53-3.47],6.519020802668968e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49357,400,1.36 [1.08-1.71],0.010138214659741
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31967,3818,1.24 [1.14-1.34],9.161778962579008e-08
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,AV-block,43401,858,1.19 [1.01-1.40],0.0394962767777833
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51420,841,1.22 [1.04-1.43],0.0155625647501173
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cardiac arrest,28531,382,1.64 [1.27-2.12],0.0001506245008819
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42882,339,1.19 [0.91-1.54],0.2025650293385795
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",42733,190,1.28 [0.90-1.81],0.171486005059231
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51531,98,1.19 [0.75-1.90],0.4676153023635745
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Conduction disorders,44640,2097,1.18 [1.06-1.31],0.002139652333721
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,48790,4155,0.91 [0.84-0.98],0.0092603006115582
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44977,15111,0.91 [0.87-0.95],3.0499357300231003e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48763,522,2.28 [1.87-2.78],2.134801973320549e-16
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Endocarditis,42688,145,1.27 [0.85-1.90],0.2346272882605046
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51122,2202,1.40 [1.27-1.54],2.420759611885204e-11
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypertension,46810,12982,0.86 [0.82-0.89],1.826986398467151e-12
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, essential",46846,13018,0.87 [0.83-0.90],6.57898927779737e-11
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51190,155,1.57 [1.09-2.27],0.0151117867446233
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34181,353,1.86 [1.44-2.41],2.355720339237318e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34095,267,12.14 [9.84-14.97],2.3425122621091536e-120
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypotension,51247,2358,1.42 [1.29-1.56],8.683522299380637e-13
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,49695,214,1.10 [0.80-1.52],0.5524779873139554
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49128,4457,0.91 [0.85-0.98],0.0104135879598193
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50787,1119,1.17 [1.02-1.35],0.026103047466011
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43264,721,1.32 [1.10-1.57],0.0025119586589526
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50571,1678,0.92 [0.82-1.03],0.1547715669705361
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46085,1414,0.91 [0.80-1.04],0.1679069807883623
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51344,307,0.93 [0.71-1.22],0.605129834784048
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51475,618,0.81 [0.67-0.99],0.0352054134067535
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Oesophageal varices,48351,110,1.08 [0.69-1.69],0.7426832504096306
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other aneurysm,49112,155,1.54 [1.06-2.24],0.0242706968192175
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other arrhythmias,43389,846,1.19 [1.01-1.41],0.0386835962660683
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49159,202,1.84 [1.33-2.53],0.0002250093808362
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49436,479,1.52 [1.23-1.88],0.0001017593193948
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,42898,355,1.24 [0.96-1.60],0.1027043824798554
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other disorders of veins,48439,198,1.88 [1.37-2.60],0.0001147515197878
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48336,95,1.48 [0.92-2.38],0.1096410167045861
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,48664,129,1.21 [0.80-1.83],0.3649470769443281
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48516,275,1.74 [1.33-2.29],6.547000433963021e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44613,2070,1.36 [1.22-1.51],6.954044549609561e-09
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,48998,109,2.04 [1.32-3.17],0.0014442218824311
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50034,1077,1.50 [1.30-1.73],2.2411391256055377e-08
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50308,689,1.65 [1.39-1.95],1.0917287934943128e-08
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",49759,1224,1.26 [1.10-1.43],0.0008036872463999
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28828,679,1.18 [0.97-1.43],0.0942788487176271
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49699,804,1.43 [1.22-1.69],1.4905201491963075e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48922,681,1.84 [1.55-2.20],9.739151155082024e-12
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50568,949,1.40 [1.21-1.63],1.1218384833643966e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51393,1320,1.31 [1.16-1.49],2.5967676340730905e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43239,696,1.09 [0.91-1.31],0.3640575037329433
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50297,678,1.65 [1.39-1.96],1.1224601251869153e-08
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,48920,385,1.63 [1.29-2.06],4.91247925441688e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50764,1283,1.16 [1.02-1.32],0.0265430644150821
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50723,1360,1.16 [1.02-1.32],0.021303733710895
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,49639,118,0.92 [0.60-1.43],0.7174939347136036
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49119,163,1.21 [0.84-1.76],0.3092502765085278
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50136,468,0.96 [0.77-1.19],0.7013460742418951
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49413,520,0.76 [0.62-0.93],0.0090685792319243
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Varicose veins,49091,850,1.49 [1.27-1.75],1.00196273893535e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,48983,169,0.98 [0.68-1.41],0.9108654790475812
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51081,1493,1.52 [1.35-1.71],5.725020809027258e-12
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51293,718,1.14 [0.96-1.36],0.1335223514849827
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45077,2846,1.01 [0.93-1.11],0.7960268394253708
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Any mental disorder,50231,8000,1.01 [0.96-1.07],0.7067233843540642
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51198,849,1.03 [0.88-1.21],0.6959870941461597
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45401,3170,1.02 [0.94-1.11],0.650760067860881
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42411,180,1.15 [0.81-1.63],0.4431885237843861
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Smoking dependency,50464,2743,0.98 [0.89-1.07],0.6131659837090753
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45494,3263,1.00 [0.92-1.08],0.9442755294009278
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Vascular dementia,50509,252,1.14 [0.85-1.53],0.3687184605747708
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Alzheimer disease,51533,659,1.09 [0.91-1.30],0.3574547327324374
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",34725,116,1.15 [0.74-1.78],0.5311392087928212
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Bell's palsy,47980,158,1.28 [0.88-1.86],0.1890777539973886
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48801,979,0.86 [0.74-1.00],0.0573486444599706
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Cerebral cysts,50713,462,1.34 [1.08-1.66],0.0088530909920818
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51374,649,1.27 [1.06-1.53],0.009417060704549
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50534,99,0.82 [0.51-1.31],0.4009517139949325
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51499,120,1.53 [1.00-2.33],0.048074913343568
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50399,148,1.21 [0.82-1.77],0.3449448727250205
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Epilepsy,48405,566,1.63 [1.34-1.98],9.017261272466736e-07
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,50575,2736,1.08 [0.99-1.18],0.0881641513027498
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51448,1198,1.00 [0.87-1.14],0.9553202070873964
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50348,5157,1.30 [1.22-1.39],2.870216814226901e-15
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Generalized epilepsy,50775,105,1.86 [1.19-2.90],0.0065034260022709
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Hemiplegia,51231,506,1.41 [1.15-1.73],0.0009773183305465
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Hydrocephalus,50373,122,0.86 [0.56-1.33],0.5072094830910017
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51496,136,1.11 [0.74-1.67],0.6009729785260014
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,47971,149,0.79 [0.53-1.16],0.2259273335067365
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,47984,162,0.95 [0.66-1.38],0.7965425394195524
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Memory loss,50224,217,1.00 [0.72-1.37],0.9791004447950554
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Migraine,48552,713,1.04 [0.87-1.24],0.7035726995437861
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51393,644,1.09 [0.90-1.31],0.3783564891877098
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Motor neuron disease,34921,274,0.81 [0.61-1.09],0.1695231420034918
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51201,206,0.95 [0.68-1.32],0.7591905514095985
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50208,2386,1.02 [0.93-1.12],0.6771725852576097
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Neurological diseases,48590,7523,1.07 [1.02-1.13],0.0123806577516615
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,50838,403,1.20 [0.96-1.52],0.1141795843531849
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48645,823,1.03 [0.88-1.22],0.6918855896144358
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51382,594,1.75 [1.45-2.11],5.238067306004426e-09
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40982,1291,1.11 [0.98-1.27],0.1076983529412585
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50399,148,1.63 [1.11-2.38],0.0122211200924085
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50531,280,1.43 [1.09-1.89],0.0109815813709022
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,50578,328,1.25 [0.96-1.61],0.091645238997194
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other facial nerve disorders,48010,188,1.28 [0.91-1.80],0.1557737082524716
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other headache syndromes,47951,112,1.01 [0.65-1.58],0.968395801776205
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other neurological diseases,51290,1039,1.24 [1.08-1.44],0.0032688294501339
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other sleep disorders,48960,1121,0.97 [0.84-1.12],0.6746107989520049
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Parkinson's disease,51486,848,0.95 [0.81-1.11],0.501983110312888
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50363,112,1.23 [0.79-1.92],0.3653855886649665
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Restless leg syndrome,51532,154,1.55 [1.07-2.24],0.0210271758211203
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Sleep apnoea,51047,963,0.96 [0.83-1.12],0.6468632524434845
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Small fibre neuropathy,50886,98,1.60 [1.00-2.55],0.0494967495633068
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51506,328,0.87 [0.67-1.13],0.2832651279462786
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,47925,103,1.27 [0.80-2.01],0.3088787207962408
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51533,666,1.09 [0.91-1.30],0.3518780304533894
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50436,245,1.22 [0.91-1.63],0.1934330862377911
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50395,196,1.13 [0.81-1.58],0.4802959670445276
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,50724,793,0.89 [0.75-1.05],0.1583719254825416
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51187,468,1.02 [0.82-1.27],0.8480853421875999
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49537,106,0.86 [0.55-1.37],0.5349889771081118
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49542,111,0.68 [0.43-1.08],0.1027481964501647
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51316,105,1.06 [0.67-1.67],0.799651264761247
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,51017,294,1.12 [0.85-1.48],0.4051060771590227
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4195,121,7.31 [5.39-9.94],3.771341857139342e-37
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5082,203,2.80 [2.15-3.64],1.7528976553741222e-14
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50382,183,1.51 [1.07-2.13],0.0194152050039045
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51103,2066,1.02 [0.92-1.13],0.7346361540824639
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50802,1371,1.00 [0.88-1.14],0.969420343185931
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,49871,440,1.15 [0.92-1.43],0.2246498189339501
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51365,1434,0.93 [0.82-1.05],0.2563657747102805
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51514,135,1.19 [0.79-1.78],0.4024558129647785
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51220,1289,0.90 [0.79-1.03],0.1230917326541051
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51445,722,0.99 [0.83-1.18],0.9233036193023838
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51346,355,1.18 [0.92-1.51],0.1998997989207449
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49548,117,1.13 [0.73-1.73],0.5895808789565238
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49565,134,0.91 [0.60-1.36],0.6392584930151208
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49541,110,1.02 [0.65-1.60],0.928237991089123
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51345,1402,1.02 [0.90-1.15],0.8070630813730254
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50304,361,1.05 [0.82-1.35],0.6840031971429414
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50025,94,0.79 [0.49-1.28],0.3391973046250811
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,50917,194,0.92 [0.65-1.29],0.6221924401974621
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51267,544,1.08 [0.89-1.33],0.4345426959867468
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50314,383,0.94 [0.74-1.20],0.6241173218158693
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51206,215,1.17 [0.85-1.62],0.3257206328561104
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50882,939,1.00 [0.86-1.17],0.9556061247139748
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50480,281,1.31 [0.99-1.73],0.055030273494026
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48348,4337,1.01 [0.94-1.09],0.7352482036716343
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51194,471,1.02 [0.82-1.27],0.8434556894449816
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51491,305,1.32 [1.01-1.72],0.041515999703104
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50247,816,0.99 [0.84-1.17],0.9065456832272416
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,50848,125,0.97 [0.64-1.48],0.8969916931843661
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51489,110,1.05 [0.67-1.64],0.8457584727316696
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,49596,165,1.22 [0.85-1.75],0.2803131960929753
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49728,297,0.81 [0.62-1.07],0.1392925528495865
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49276,239,0.82 [0.60-1.11],0.192982999159727
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50052,121,1.24 [0.81-1.90],0.323888337451313
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49161,124,0.64 [0.42-0.99],0.0438470889283141
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50114,171,0.98 [0.69-1.41],0.9216160512975116
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50332,389,0.92 [0.73-1.17],0.5044508585357264
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,49683,252,1.28 [0.96-1.71],0.098534759344603
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49258,221,0.95 [0.68-1.31],0.7390387054126837
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49208,171,1.11 [0.77-1.59],0.578483979481969
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,47602,3591,0.96 [0.89-1.04],0.3410662824189502
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49574,143,1.35 [0.92-2.00],0.1267979449293479
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51015,816,1.12 [0.95-1.32],0.1771246829024635
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50317,118,0.73 [0.47-1.13],0.1592241168890139
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50539,340,1.27 [0.99-1.64],0.0598483019062336
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51106,176,1.06 [0.74-1.51],0.7556295272758149
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51442,241,1.03 [0.76-1.40],0.8245444898342907
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51274,260,0.84 [0.63-1.13],0.2559648032073687
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51051,121,1.45 [0.95-2.21],0.0846659097079775
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,51054,124,0.84 [0.55-1.29],0.421678672771653
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51338,1788,1.05 [0.94-1.17],0.3936647176548387
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,50828,1278,1.07 [0.94-1.22],0.3319774796429047
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,49802,252,1.00 [0.74-1.34],0.9938664044680412
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,49722,172,1.13 [0.79-1.62],0.5020314706368223
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute pharyngitis,51050,149,1.38 [0.94-2.01],0.1014000380256348
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51327,426,1.28 [1.02-1.61],0.0309180778416941
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51028,127,1.43 [0.95-2.16],0.0872779133782578
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,All influenza,47487,237,1.80 [1.33-2.44],0.0001464793790071
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47482,232,1.77 [1.30-2.40],0.000272066428101
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35298,235,0.90 [0.65-1.23],0.5098835827893864
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Allergic rhinitis,51267,558,0.95 [0.78-1.16],0.6128547880359159
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38036,3517,0.99 [0.92-1.08],0.8767921001693304
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38530,3467,1.00 [0.92-1.09],0.9959037274517069
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),50717,275,2.09 [1.59-2.73],1.0885762288756449e-07
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47411,161,1.91 [1.32-2.75],0.0005629508928496
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Bronchiectasis,44676,709,1.09 [0.91-1.29],0.3657474558135113
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44082,115,1.67 [1.09-2.57],0.0197102743777092
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49517,5550,1.00 [0.94-1.07],0.9184348624358444
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",48796,141,1.10 [0.74-1.64],0.6334492434721617
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Chronic sinusitis,48961,306,0.92 [0.70-1.21],0.5611563664436069
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51129,2382,1.00 [0.91-1.10],0.9799979398429712
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Deviated nasal septum,48866,211,0.83 [0.60-1.16],0.2805526703272575
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47421,10496,1.05 [1.00-1.10],0.0409876186860633
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49382,727,0.82 [0.68-0.97],0.0237503454713396
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Early onset COPD,49381,634,0.93 [0.77-1.12],0.427089456947256
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Emphysema,44592,625,0.93 [0.77-1.13],0.4751461598077384
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48943,569,1.03 [0.85-1.26],0.7515313453793583
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51082,3832,1.29 [1.20-1.39],3.0010726422887513e-11
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Interstitial lung disease,49013,639,1.00 [0.83-1.21],0.9771196933594096
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Later onset COPD,49531,1748,1.01 [0.91-1.13],0.8236712803046621
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51508,656,1.48 [1.24-1.77],1.7933137735474057e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Nasal polyp,48869,214,1.06 [0.77-1.47],0.7107301930450836
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51037,1939,1.28 [1.15-1.42],4.565343366492186e-06
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other diseases of pleura,51066,3979,1.27 [1.18-1.37],2.1982818268898456e-10
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50320,1665,0.86 [0.76-0.96],0.0091552238360959
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other pleural conditions,47191,104,1.62 [1.02-2.56],0.0404634125005096
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51356,798,1.18 [1.00-1.39],0.0480265380717131
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51321,2589,1.28 [1.17-1.40],1.648820372809973e-07
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pleural effusion,49069,1982,1.40 [1.26-1.56],2.6425127352779107e-10
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pleural plaque,47399,312,1.15 [0.88-1.51],0.2920023426312289
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",50578,3328,1.30 [1.19-1.41],3.878551743797937e-10
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51378,526,1.70 [1.40-2.08],1.4252503920807e-07
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pneumothorax,47321,234,1.22 [0.90-1.67],0.1979215251518343
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pollen allergy,51485,475,0.93 [0.75-1.16],0.5422090801113805
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pulmonary oedema,50687,129,2.41 [1.64-3.53],6.3857507999655175e-06
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35172,109,1.50 [0.95-2.36],0.0793377958316929
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50994,1896,1.32 [1.19-1.47],3.373775869546544e-07
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49215,560,0.94 [0.77-1.15],0.528767430516494
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Viral pneumonia,47749,499,1.18 [0.95-1.46],0.1250672531393936
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",50750,412,1.14 [0.90-1.43],0.2827552788285589
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23743,226,0.68 [0.49-0.94],0.0191769876409224
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36378,127,0.99 [0.65-1.52],0.9742690261015344
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute appendicitis,51212,287,0.96 [0.73-1.28],0.7910603065620673
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute gastritis,38775,179,1.40 [0.98-1.99],0.0627552467382228
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute pancreatitis,47848,368,1.00 [0.78-1.28],0.9928957720970776
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute peritonitis,50584,188,2.32 [1.68-3.21],3.928072313774735e-07
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Alcoholic liver disease,49760,150,1.29 [0.88-1.89],0.192024256201144
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Barrett oesophagus,39466,870,1.03 [0.88-1.21],0.7195090136911266
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",47684,204,1.11 [0.80-1.54],0.5278839276343394
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",50686,204,1.10 [0.80-1.53],0.5546998675915298
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Cholecystitis,47887,407,1.22 [0.96-1.53],0.0991871446710246
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Cholelithiasis,49470,1990,0.86 [0.77-0.95],0.0038788262274208
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Chronic gastritis,39202,606,0.94 [0.78-1.15],0.5655355982197985
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47577,97,1.03 [0.64-1.66],0.9069228589995076
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51244,209,1.25 [0.91-1.72],0.1682436786057854
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Coeliac disease,48319,245,0.53 [0.39-0.73],5.827254923162936e-05
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Collagenous colitis,48164,163,1.05 [0.73-1.53],0.7904596096209138
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51226,372,0.98 [0.76-1.25],0.8595283884337559
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Constipation,51021,3344,1.11 [1.02-1.20],0.01192245324265
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Crohn disease,48189,188,1.26 [0.89-1.79],0.1833872311772372
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50820,138,1.06 [0.71-1.59],0.7732075697713164
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48179,178,1.34 [0.94-1.91],0.1049461899292712
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Dental caries,50041,457,0.99 [0.80-1.24],0.9540580063321736
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46237,4450,0.99 [0.92-1.06],0.749930725573315
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of appendix,51287,362,0.90 [0.70-1.16],0.4249386586786596
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of liver,51292,1682,1.03 [0.92-1.15],0.6431797144362514
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47226,8630,1.00 [0.95-1.05],0.9370395904133836
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50696,1112,1.09 [0.94-1.25],0.2530722174075193
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51357,961,1.18 [1.01-1.37],0.0317380969799606
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49813,229,1.23 [0.90-1.67],0.2009445690781642
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49516,129,1.01 [0.66-1.53],0.9694127324002906
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of the digestive system,50908,2834,1.04 [0.95-1.14],0.3771660231717264
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of tongue,49547,221,1.25 [0.91-1.72],0.1658672777380332
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50283,2803,0.95 [0.87-1.04],0.2873746903609144
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42551,6300,0.91 [0.86-0.97],0.0018120492060591
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Duodenal ulcer,38994,398,1.07 [0.85-1.36],0.5613497132327201
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51368,321,0.90 [0.69-1.17],0.4266757689659587
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51353,112,1.08 [0.69-1.70],0.7335592221622074
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,49862,252,1.28 [0.96-1.72],0.0939925416820728
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36544,293,1.00 [0.75-1.32],0.9724352910496228
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Functional dyspepsia,39687,1091,0.82 [0.71-0.95],0.0081636711772394
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastric ulcer,39316,720,1.22 [1.03-1.46],0.0246070536053267
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43581,4985,0.94 [0.87-1.00],0.0521718077664204
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39670,1074,1.19 [1.03-1.38],0.0172468892095884
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39891,16556,0.96 [0.92-0.99],0.0251525318261872
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,GI-bleeding,50395,2321,1.10 [1.00-1.22],0.0503045723424095
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,49691,107,1.55 [0.99-2.42],0.0558770909365966
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38197,2507,0.89 [0.81-0.98],0.0194622549323491
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",49737,127,1.52 [1.01-2.29],0.0463484728624675
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Hernia,48277,6490,0.97 [0.92-1.03],0.3317800244838421
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Impacted teeth,51367,104,1.10 [0.69-1.75],0.70351857061259
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Impaction of intestines,36361,110,1.10 [0.70-1.73],0.6719391526033245
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Inguinal hernia,43593,1806,0.92 [0.82-1.02],0.1217071291660831
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41993,206,0.82 [0.59-1.15],0.2547822370617572
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36444,193,1.37 [0.97-1.92],0.0722852752480441
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48359,285,0.60 [0.45-0.80],0.0004786709185642
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37360,1109,1.02 [0.88-1.18],0.7808708620942643
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51475,728,0.72 [0.61-0.86],0.0003366029089098
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49512,1511,1.22 [1.08-1.38],0.0011523063441842
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50012,2011,1.15 [1.03-1.27],0.0110491417115045
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38971,375,0.98 [0.77-1.26],0.8793867253018528
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oesophagitis,39791,1195,1.17 [1.02-1.34],0.0275874384459377
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51436,271,0.91 [0.68-1.22],0.5415887869319704
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,41925,138,0.83 [0.56-1.25],0.3793960406431714
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38965,2714,0.89 [0.81-0.98],0.0159578898541726
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48042,562,1.04 [0.85-1.26],0.7244062021554141
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,47792,312,0.94 [0.72-1.22],0.6261607676186414
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of intestine,39739,3488,0.98 [0.91-1.07],0.7111193651213585
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of intestines,47519,11268,0.98 [0.94-1.02],0.338326424934022
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49504,411,0.88 [0.69-1.11],0.2732224842998705
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of liver,50983,1373,1.01 [0.89-1.14],0.914259191092937
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39924,1328,1.07 [0.94-1.22],0.2804431001923718
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of pancreas,47784,304,1.19 [0.91-1.56],0.1969627018373633
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51220,824,1.02 [0.86-1.20],0.8224931329847065
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40498,1902,0.96 [0.86-1.07],0.4462619904179741
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50426,2352,1.11 [1.01-1.23],0.0321614152671621
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49959,375,0.93 [0.73-1.19],0.5671971487455476
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,39691,3440,1.07 [0.99-1.16],0.1027514792843775
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42613,4017,1.01 [0.93-1.09],0.8571158186751688
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,49809,199,0.88 [0.63-1.23],0.4594347677015326
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49765,1764,1.20 [1.08-1.35],0.0012189074973483
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36939,688,1.06 [0.88-1.27],0.5451716050408719
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51333,132,1.07 [0.70-1.62],0.7600031790717361
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37230,979,1.10 [0.95-1.28],0.2051974866579769
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48374,300,1.15 [0.87-1.51],0.319253390332825
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51511,110,1.31 [0.84-2.05],0.2350006108164329
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,49594,232,1.53 [1.13-2.09],0.0063160378674802
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Toxic colitis,48113,112,1.45 [0.93-2.26],0.0974388027156688
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39130,534,1.05 [0.85-1.29],0.6637930139996006
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ulcerative colitis,48321,320,0.94 [0.72-1.22],0.6372203297152195
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48268,267,0.87 [0.65-1.16],0.3372863383695986
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Umbilical hernia,42333,546,0.93 [0.76-1.14],0.4887951655607704
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36598,347,1.05 [0.81-1.35],0.7345429405717773
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ventral hernia,42308,521,1.01 [0.82-1.25],0.8984345159361277
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Volvulus,36410,159,0.82 [0.56-1.19],0.2973520449481523
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51370,592,1.42 [1.17-1.72],0.0003231365345805
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,50886,144,0.95 [0.64-1.42],0.8168233769742409
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47454,319,1.05 [0.80-1.37],0.728892191441197
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50265,1405,1.62 [1.43-1.83],1.7928110304944986e-14
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49210,350,1.28 [0.99-1.65],0.0554138048562463
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,47954,819,1.67 [1.43-1.96],2.8975510047974183e-10
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,50919,549,0.95 [0.78-1.17],0.6414042819073891
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51333,963,1.11 [0.96-1.30],0.1609489288693076
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50465,95,1.47 [0.91-2.38],0.1145788305845775
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48427,6390,1.16 [1.09-1.23],1.409112185124329e-06
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50624,892,0.84 [0.71-0.98],0.0268670285323865
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50359,627,0.76 [0.63-0.92],0.0055347507523766
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50751,1891,1.44 [1.30-1.61],1.7984246171931656e-11
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51500,108,0.94 [0.59-1.48],0.7772845182274076
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47249,114,1.46 [0.94-2.26],0.089424151249852
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49836,104,0.90 [0.57-1.43],0.6572745197463168
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,50899,529,0.98 [0.79-1.20],0.8160614284240699
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48037,902,1.22 [1.04-1.43],0.0129999743313897
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47263,128,1.65 [1.09-2.50],0.016931000807975
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51359,162,1.92 [1.35-2.74],0.0002786926701143
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49236,376,1.33 [1.04-1.69],0.02252412258026
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51132,390,1.06 [0.83-1.34],0.6371729970864695
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50499,129,2.60 [1.77-3.81],1.0091704463905198e-06
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47267,132,0.93 [0.61-1.41],0.7279688789326648
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50382,3247,1.34 [1.23-1.45],3.9975277186059966e-12
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48113,978,1.22 [1.05-1.42],0.009377105054507
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47271,136,1.51 [1.01-2.26],0.0436543700226988
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51357,615,1.03 [0.85-1.24],0.7783971493740638
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50510,140,1.35 [0.91-1.99],0.139073930083984
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51247,505,1.05 [0.85-1.29],0.6604765248855968
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51425,647,1.39 [1.16-1.67],0.0004545862638877
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47385,250,1.08 [0.80-1.47],0.6003666664678358
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47669,534,1.07 [0.87-1.31],0.5251012311537547
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51405,627,1.41 [1.17-1.70],0.0003317995686285
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47610,475,2.26 [1.84-2.77],5.170837376351053e-15
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51472,275,1.57 [1.19-2.07],0.0015068403472876
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44212,219,0.83 [0.60-1.15],0.2609151679626298
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,46885,11248,1.11 [1.06-1.16],1.0060195715292704e-05
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44066,8429,1.09 [1.04-1.15],0.0007253884268566
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44146,153,1.07 [0.73-1.58],0.7186331863663855
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44685,307,1.31 [1.00-1.72],0.0468587133950199
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44732,354,1.69 [1.32-2.16],3.19424209379452e-05
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51034,181,1.14 [0.80-1.61],0.4770906261913933
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44579,201,1.41 [1.01-1.96],0.042536104567684
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37896,2259,1.18 [1.07-1.31],0.0009912870922207
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51259,374,1.19 [0.93-1.51],0.1636916163205615
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45274,896,1.23 [1.05-1.44],0.0091156580055828
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43546,14475,1.10 [1.05-1.14],6.256962955021239e-06
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47562,232,1.71 [1.26-2.32],0.0005158945530702
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44297,304,1.32 [1.01-1.72],0.0423778537511572
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45115,1122,0.98 [0.85-1.13],0.7775340357398415
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,49684,5306,1.08 [1.01-1.15],0.0239760880957443
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44540,547,1.28 [1.05-1.57],0.0149155978454977
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44435,442,1.19 [0.95-1.49],0.1363154260314522
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44256,263,0.92 [0.68-1.24],0.5772955655355618
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50252,139,0.93 [0.63-1.39],0.7383970331203751
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39010,3373,1.12 [1.03-1.21],0.008525193230619
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36849,1212,1.59 [1.39-1.82],6.763283618958587e-12
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51379,1195,1.56 [1.36-1.78],8.105881968117684e-11
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35786,149,0.95 [0.64-1.40],0.7796245670713606
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36295,658,1.36 [1.13-1.64],0.0010000988028532
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44596,603,0.93 [0.76-1.13],0.4419662057370233
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36910,1273,1.14 [1.00-1.30],0.0575864063529854
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44490,112,2.20 [1.43-3.38],0.0003191912759198
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45635,1257,1.13 [0.99-1.29],0.0708538613753963
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44987,609,1.00 [0.83-1.22],0.9871698964597846
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36826,1189,1.12 [0.97-1.28],0.1245182222300588
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44153,160,1.10 [0.76-1.60],0.6160966675650688
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44114,121,1.31 [0.85-2.00],0.219091619063501
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47476,146,1.73 [1.18-2.53],0.0047007597495253
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,50758,3428,1.42 [1.31-1.54],8.835255145495314e-18
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,49574,2244,1.46 [1.32-1.61],5.339971364202865e-14
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51247,901,1.10 [0.94-1.28],0.2370941183841226
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40604,4967,1.13 [1.05-1.21],0.0004456972487312
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35763,126,1.14 [0.74-1.74],0.5589437716734564
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44179,186,1.58 [1.12-2.23],0.00846421169019
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35736,99,1.23 [0.76-1.97],0.4019837978381222
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35889,252,1.21 [0.90-1.64],0.2058555618533601
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47811,481,1.31 [1.06-1.63],0.0132547482687272
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48094,764,1.45 [1.23-1.72],1.65852862362547e-05
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51467,201,1.21 [0.87-1.69],0.2528685093206488
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",47981,3603,1.11 [1.02-1.20],0.0101067692422473
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44194,201,1.44 [1.03-2.01],0.0316110553781988
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35907,270,1.29 [0.97-1.73],0.079498503073277
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45834,1456,1.07 [0.95-1.21],0.2725419809715331
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39929,4292,1.24 [1.15-1.33],5.803805870384724e-09
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50301,188,1.17 [0.83-1.65],0.3586702362400975
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51496,137,0.92 [0.61-1.37],0.6769492904127572
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44156,163,0.91 [0.63-1.32],0.6143375809372816
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46484,2491,1.20 [1.09-1.32],0.0001269372770907
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44173,180,1.62 [1.15-2.29],0.0061469100247127
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38852,3215,1.07 [0.98-1.16],0.1291599495830431
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47554,224,1.03 [0.75-1.41],0.860969064415011
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44101,108,1.23 [0.78-1.94],0.3805592845799556
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,44692,314,1.13 [0.86-1.47],0.3819169099061479
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45098,1105,1.42 [1.24-1.63],7.236935479793785e-07
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50820,707,1.14 [0.96-1.36],0.141192842648848
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45518,1140,1.33 [1.16-1.53],4.464949608245685e-05
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51271,875,1.09 [0.93-1.28],0.2907178605107143
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51488,108,0.78 [0.50-1.24],0.2943518082957804
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44371,378,1.08 [0.84-1.38],0.5486265249827054
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40799,1505,1.36 [1.20-1.53],7.963869421218013e-07
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45153,1160,1.23 [1.08-1.42],0.002774963990081
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44450,457,1.25 [1.01-1.56],0.0438822878119872
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35746,109,1.38 [0.88-2.16],0.1629633728327228
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40583,4946,1.11 [1.04-1.19],0.0015520829129739
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36947,1310,1.11 [0.97-1.26],0.1195440026831935
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,50574,461,1.01 [0.81-1.26],0.909565320273873
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51400,134,1.58 [1.06-2.36],0.0238270933103811
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47203,102,1.15 [0.73-1.80],0.5491820955935806
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35777,140,0.97 [0.64-1.45],0.8651917357896493
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44578,200,0.88 [0.63-1.24],0.4663724381851081
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36550,913,1.12 [0.95-1.30],0.1710180415153532
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44609,616,1.06 [0.88-1.28],0.5536276799370317
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44884,506,1.20 [0.97-1.48],0.0971655586184634
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,44759,381,1.36 [1.07-1.74],0.0118567904114062
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40290,116,1.04 [0.67-1.61],0.8754130636611147
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51496,116,0.76 [0.49-1.19],0.2307694581886983
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45171,1178,0.97 [0.84-1.11],0.6648893127414968
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],50300,187,1.46 [1.04-2.05],0.0309823267195961
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49124,5131,1.14 [1.07-1.22],7.138334190866249e-05
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44255,262,0.87 [0.65-1.17],0.3521210999808133
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45457,1079,1.01 [0.87-1.16],0.9352947385331238
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,48715,464,1.09 [0.88-1.36],0.4260262870544473
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,44793,415,1.06 [0.84-1.34],0.6355201250562297
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47474,3096,1.08 [1.00-1.18],0.0647688851504516
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46411,2033,1.12 [1.01-1.24],0.0362910979428929
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44102,109,1.37 [0.87-2.14],0.1706811711252662
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50380,267,1.26 [0.95-1.68],0.1110406689147462
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44315,322,0.84 [0.64-1.09],0.1873661622164551
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44145,152,0.98 [0.67-1.44],0.924329892700448
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35754,117,1.34 [0.87-2.08],0.1863610890375642
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49443,3158,2.02 [1.86-2.20],2.844238929540037e-60
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20799,99,0.67 [0.41-1.08],0.0988870820117555
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27080,111,1.20 [0.77-1.88],0.4208336448619233
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,50892,643,0.75 [0.62-0.90],0.0023729900460971
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50416,167,0.94 [0.65-1.35],0.7299597548354612
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49341,3056,3.73 [3.43-4.04],2.90816415484211e-220
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51105,163,10.04 [7.77-12.97],1.1538659831610396e-69
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51044,603,1.39 [1.15-1.68],0.0006627767216775
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Cystitis,45358,469,0.99 [0.79-1.23],0.9246750557199294
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Dialysis,46440,155,29.70 [23.19-38.02],2.6582179004794635e-159
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22463,3302,1.00 [0.92-1.08],0.9514425483154842
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27311,342,0.90 [0.70-1.16],0.4241635683675708
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Endometriosis,20878,178,0.83 [0.58-1.19],0.3040466807570917
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21100,400,0.73 [0.58-0.93],0.011629815284041
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21720,1020,0.68 [0.58-0.79],2.731308172194151e-07
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43001,10718,1.13 [1.07-1.18],9.674865822415226e-07
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51109,167,5.99 [4.41-8.15],2.6284807046753424e-30
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hydrocele,19367,206,0.92 [0.66-1.29],0.6392188509258778
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46275,587,1.24 [1.01-1.52],0.0361134439921346
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21759,2598,0.98 [0.89-1.08],0.7115308885036232
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27235,408,0.83 [0.66-1.05],0.1161848749271685
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19396,235,0.93 [0.68-1.27],0.639442507623605
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Irregular menses,27321,129,0.75 [0.49-1.15],0.1894693590928197
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21007,307,0.73 [0.55-0.96],0.0254198032281666
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45049,160,1.23 [0.85-1.79],0.2800202353540559
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23188,2488,0.82 [0.74-0.90],3.729722560362889e-05
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19268,107,0.62 [0.39-0.99],0.0473337489480531
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20845,145,1.07 [0.72-1.58],0.7521121939852566
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51506,131,0.90 [0.59-1.35],0.6075692596513094
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51516,135,0.70 [0.46-1.05],0.0819657276900213
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49423,4534,1.09 [1.02-1.17],0.0156262528778215
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46330,1441,1.00 [0.88-1.14],0.9543668899661856
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27089,120,0.79 [0.51-1.21],0.2774641114597023
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51396,955,1.73 [1.49-2.01],5.58844109304544e-13
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19468,307,1.39 [1.06-1.83],0.0161686150779355
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19438,277,1.07 [0.80-1.42],0.6557063006338979
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19390,229,1.09 [0.79-1.49],0.6070826582413842
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51453,139,1.31 [0.88-1.94],0.1808384373563636
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48384,3495,1.18 [1.09-1.28],3.940471356193621e-05
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27038,211,0.98 [0.71-1.36],0.9006498024135631
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20856,156,0.90 [0.61-1.32],0.5810388480626141
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21076,376,0.78 [0.61-0.99],0.0412706045101148
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20813,113,0.65 [0.42-1.02],0.0613759956755423
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20908,208,0.79 [0.57-1.10],0.1612859201103293
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46370,682,1.41 [1.17-1.70],0.0003538073991741
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,50756,315,2.02 [1.56-2.61],8.815111755841267e-08
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21011,311,1.09 [0.83-1.42],0.539703430153438
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20808,108,1.16 [0.73-1.83],0.5314795512188406
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21358,658,0.84 [0.70-1.01],0.0660549161531774
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20864,164,0.83 [0.57-1.20],0.3125664314026589
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21303,603,0.75 [0.62-0.91],0.0041288541495234
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51038,96,2.71 [1.71-4.30],2.1136413331371224e-05
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19424,263,1.16 [0.86-1.56],0.3269414715259486
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51035,5347,2.01 [1.88-2.14],4.232803758610164e-98
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",45926,238,1.95 [1.42-2.67],3.134154345691011e-05
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46543,258,5.21 [3.92-6.93],5.735442935165361e-30
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50363,114,0.91 [0.58-1.43],0.694281264974681
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45331,442,1.06 [0.84-1.33],0.6393221358369423
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51045,796,0.78 [0.66-0.93],0.0048297043053848
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20843,143,0.59 [0.40-0.88],0.009363166868226
